Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,033 USD | +0.92% | -1.73% | +17.59% |
03/07 | Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval | MT |
03/07 | Sanofi obtains EU approval for Dupixent | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.59% | 110B | |
+16.89% | 121B | |
+17.23% | 25.98B | |
-24.48% | 19.27B | |
-18.56% | 15.99B | |
-18.23% | 15.66B | |
-47.75% | 14.5B | |
+57.08% | 14.47B | |
+4.98% | 13.91B | |
+120.36% | 10B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals Insider Sold Shares Worth $836,280, According to a Recent SEC Filing